About

This is the official investor website for The University of Texas System. For bondholder convenience, we have created separate investor sites for the two different debt programs that the System uses to access capital to fund its infrastructure projects: the Permanent University Fund debt program and the Revenue Financing System debt program. Please use the drop-down menu for details for each debt program.

About The University of Texas System

For nearly 140 years, The University of Texas System has been committed to improving the lives of Texans and people all over the world through education, research and health care.

The University of Texas System is one of the largest public university systems in the United States. With 14 institutions and an enrollment of more than 260,000 students, UT institutions produce more than 66,000 graduates annually, including more than one-third of the state’s undergraduate degrees and more than 60 percent of the state’s medical degrees.  Collectively, UT-owned and affiliated hospitals and clinics accounted for more than 10.6 million outpatient visits and more than 2.0 million hospital days in 2023. UT institutions also are among the most innovative in the world, collectively ranking No. 3 for most patents granted globally in 2022, and the UT System is No. 1 in Texas and No. 2 in the nation in federal research expenditures among public higher education systems. The UT System’s operating budget for FY 2025 is $32.0 billion, including $6.6 billion in sponsored programs funded by federal, state, local and private sources. With more than 134,000 faculty, health care professionals, researchers, support staff and student workers, the UT System is one of the largest employers in the state.

In addition, the UT System is home to three of the nation’s National Cancer Institute Cancer Centers – UT MD Anderson, UT Southwestern and UT Health Science Center-San Antonio – which must meet rigorous criteria for world-class programs in cancer research. Also, the U. T. System is the only system in the country to have four Clinical and Translational Science Awards from the National Institutes of Health.